The Pharmaceutical Fluid Handling Market Size is valued at USD 10.28 Bn in 2022 and is predicted to reach USD 15.31 Bn by the year 2031 at a 4.6% CAGR during the forecast period for 2023-2031.
Pharmaceutical fluid handling is essential for delivering fluid medications such as cough syrups, intravenous medicines, and complicated active pharmaceutical components. Any firm that wants to flourish and be relied upon must invest in properly handling instruments and equipment. Automation cuts down on human mistakes, decreasing the number of lost samples.
The fluid handling equipment and production unit can be cleaned directly by automated handling without additional preparation. The application of AI for automated liquid handling provides promising prospects for the development of the market, such as the control of different phases of autonomous liquid handling and the use of internet connectivity to engage remotely with handlers.
In addition, key players' increased focus on new product development and strategic collaborations led to the growth of the global pharmaceutical fluid handling market. Companies in the pharmaceutical fluid handling market can anticipate substantial development prospects and increased spending on cutting-edge technology. It drives expansion globally and is expected to boost market expansion in the coming years.
The pharmaceutical fluid handling market is segmented based on offering, tubing, application, usage, and end-users. Based on offering, equipment & solutions and services. By tubing, the market is segmented into thermoplastic elastomers, polyvinyl chloride, and silicone. By application, the market is segmented into fluid handling & management, fluid preparation, integration & automation, buffer management, and others. By usage, the market is segmented into cough syrup, intravenous products, complex active pharmaceutical ingredients, and others. By end user, the market is segmented into biotechnology companies, pharmaceutical & medical companies, and others.
The thermoplastic elastomers companies' pharmaceutical fluid handling category is expected to record a major global market share in 2022. It is attributed because thermoplastic elastomers are highly processable and can be used in any standard extrusion or injection moulding facility. They may be reused often without breaking the bank and produce fewer emissions. The pharmaceutical and biomedical industries manufacture thermoplastic elastomer tubing with a high purity level.
The biotechnology companies segment is estimated to grow rapidly in the global pharmaceutical fluid handling market. Innovative biologics for treating chronic diseases are mostly the domain of the biotechnology industry. Since the beginning of this decade, the industry has expanded thanks to more funding for R&D and more approvals from government agencies to market new products, especially in countries like the US, Germany, the UK, China, and India.
The North American pharmaceutical fluid handling market is expected to record the maximum market share in revenue in the near future. It can be attributed to the developments in healthcare infrastructure, the big domestic pharmaceutical industry and production facilities. The government also spends much on creating special industrial zones where infrastructure may be built and products can be made at a discount.
In addition, the presence of key market competitors and improvements in pharmaceutical fluid handling technology fuel expansion in the region's industries. In addition, Asia Pacific is projected to grow rapidly in the global pharmaceutical fluid handling market because of increased pharmaceutical R&D spending, rising pharmaceutical output, a maturing pharmaceutical sector, and growing financial support from the business.
| Report Attribute | Specifications |
| Market Size Value In 2022 | USD 10.28 Bn |
| Revenue Forecast In 2031 | USD 15.31 Bn |
| Growth Rate CAGR | CAGR of 4.6% from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Offering, Tubing, Application, Usage, and End User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | CIRCOR International Inc, Parker Hannifin Corp, Danaher Corp, Spirax Sarco Engineering plc, Merck KGaA, Rochling SE & Co KG, RAUMEDIC AG, Tef Cap Industries Inc, Fraser Ross Ltd, and Australian Fluid Handling Pty Ltd. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Pharmaceutical Fluid Handling Market By Offering -
Pharmaceutical Fluid Handling Market By Tubing -
Pharmaceutical Fluid Handling Market By Application -
Pharmaceutical Fluid Handling Market By Usage -
Pharmaceutical Fluid Handling Market By End User -
Pharmaceutical Fluid Handling Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.